Literature DB >> 33505743

Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors.

Jomana Madieh1, Iman Khamayseh1, Alaa Hrizat1, Abdurrahman Hamadah2, Kamel Gharaibeh1.   

Abstract

Mixed connective tissue disease (MCTD) is a rheumatic disease syndrome with overlapping features of scleroderma, systemic lupus erythematosus, and polymyositis. An extremely rare but serious complication that can occur in MCTD is scleroderma renal crisis (SRC). There have been different approaches to the treatment of SRC associated with MCTD. We present a case of MCTD with chronic features of Raynaud's phenomenon, dermatomyositis, and thrombocytopenia complicated with acute SRC which showed a great response to ACE inhibitors. Here, we advise the early and aggressive use of ACE inhibitors as soon as SRC is suspected.
Copyright © 2021 Jomana Madieh et al.

Entities:  

Year:  2021        PMID: 33505743      PMCID: PMC7808802          DOI: 10.1155/2021/8862405

Source DB:  PubMed          Journal:  Case Rep Nephrol        ISSN: 2090-665X


  25 in total

Review 1.  Scleroderma renal crisis.

Authors:  Virginia D Steen
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

2.  Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibition.

Authors:  Muhammad Abdul Mabood Khalil; Nadia Iftikhar; Syed Ather Hussain; Jackson Tan
Journal:  CEN Case Rep       Date:  2012-09-28

3.  Factors predicting development of renal involvement in progressive systemic sclerosis.

Authors:  V D Steen; T A Medsger; T A Osial; G L Ziegler; A P Shapiro; G P Rodnan
Journal:  Am J Med       Date:  1984-05       Impact factor: 4.965

4.  Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

Authors:  V D Steen; J P Costantino; A P Shapiro; T A Medsger
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

5.  Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

Authors:  Paul J DeMarco; Michael H Weisman; James R Seibold; Daniel E Furst; Weng Kee Wong; Eric L Hurwitz; Maureen Mayes; Barbara White; Fredrick Wigley; Walter Barr; Larry Moreland; Thomas A Medsger; Virginia Steen; Richard W Martin; David Collier; Arthur Weinstein; Edward Lally; John Varga; Steven R Weiner; Brian Andrews; Micha Abeles; Philip J Clements
Journal:  Arthritis Rheum       Date:  2002-11

6.  Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.

Authors:  M A Burdt; R W Hoffman; S L Deutscher; G S Wang; J C Johnson; G C Sharp
Journal:  Arthritis Rheum       Date:  1999-05

7.  The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients.

Authors:  Ragnar Gunnarsson; Oyvind Molberg; Inge-Margrethe Gilboe; Jan Tore Gran
Journal:  Ann Rheum Dis       Date:  2011-03-11       Impact factor: 19.103

Review 8.  Scleroderma renal crisis in a case of mixed connective tissue disease.

Authors:  Mukul Vij; Vinita Agrawal; Manoj Jain
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-07

Review 9.  [Undifferentiated connective tissue disease].

Authors:  Edit Bodolay; Gyula Szegedi
Journal:  Orv Hetil       Date:  2009-05-10       Impact factor: 0.540

Review 10.  Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology.

Authors:  Peri Hickman Pepmueller
Journal:  Mo Med       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.